The membrane-active regions of the hepatitis C virus E1 and E2 envelope glycoproteins

Biochemistry

Volumn 45, Issue 11, 2006, Pages 3755-3768

  Pérez Berná, Ana J ^a   Moreno, Miguel R ^a   Guillén, Jaime ^a   Bernabeu, Angela ^a   Villalaín, José ^a  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOCHEMISTRY; CELL MEMBRANES; GLYCOLS; PHOSPHOLIPIDS; PHYSIOLOGICAL MODELS; PROTEINS;

HERNIFUSION; MEMBRANE FUSION; MEMBRANE LEAKAGE; PROTEIN-PROTEIN BINDING;

VIRUSES;

GLYCOPROTEIN E1; GLYCOPROTEIN E2; HYBRID PROTEIN; PEPTIDE LIBRARY; VIRUS ENVELOPE PROTEIN;

ARTICLE; CELL MEMBRANE; GENE SEQUENCE; HEPATITIS C VIRUS; LIPID COMPOSITION; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; TARGET CELL;

BINDING SITES; HEPACIVIRUS; MEMBRANE FUSION; MEMBRANES; PEPTIDE LIBRARY; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP; VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS;

EID: 33645237530     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0523963     Document Type: Article

References (52)

1. Penin, F., Dubuisson, J., Rey, F. A., Moradpour, D., and Pawlotsky, J. M. (2004) Structural biology of hepatitis C virus, Hepatology 39, 5-19.
2. Tan, S. L., Pause, A., Shi, Y., and Sonenberg, N. (2002) Hepatitis C therapeutics: current status and emerging strategies, Nat. Rev. Drug Discovery, 867-881.
3. Wong, V. K., Cheong-Lee, C., Ford, J. A., and Yoshida, E. M. (2005) Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: Outcome after resumption of therapy, World J. Gastroenterol. 11, 5392-5393.
4. Reed, K. E., and Rice, C. M. (2000) Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties, Curr. Top. Microbiol. Immunol. 242, 55-84.
5. Simmonds, P., Alberti, A., Alter, H. J., Bonino, F., Bradley, D. W., Brechot, C., et al. (1994) A proposed system for the nomenclature of hepatitis C viral genotypes, Hepatology 19, 1321-1324.
6. Tokita, H., Okamoto, H., Iizuka, H., Kishimoto, J., Tsuda, F., Miyakawa, Y., and Mayumi, M. (1998) The entire nucleotide sequences of three hepatitis C virus isolates in genetic groups 7-9 and comparison with those in the other eight genetic groups, J. Gen. Virol 79, 1847-1857.
7. Pawlotsky, J. M. (2003) Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C, Antiviral Res. 59, 1-11.
8. Bartosch, B., Dubuisson, J., and Cosset, F.-L. (2003) Infectious hepatitis C pseudoviruses containing functional E1E2 envelope protein complexes, J. Exp. Med. 197, 633-642.
9. Cocquerel, L., Duvet, S., Meunier, J. C., Pillez, A., Cacan, R., Wychowski, C., and Dubuisson, J. (1999) The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum, J. Virol. 73, 2641-2649.
10. Cocquerel, L., Meunier, J. C., Pillez, A., Wychowski, C., and Dubuisson, J. (1998) A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2, J. Virol. 72, 2183-2191.
11. Deleersnyder, V., Pillez, A., Wychowski, C., Blight, K., Xu, J., Hahn, Y. S., Rice, C. M., and Dubuisson, J. (1997) Formation of native hepatitis C virus glycoprotein complexes, J. Virol. 71, 697-704.
12. Op De Beeck, A., Montserret, R., Duvet, S., Cocquerel, L., Cacan, R., Barberot, B., Le Maire, M., Penin, F., and Dubuisson, J. (2000) The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization, J. Biol. Chem. 275, 31428-31437.
13. Garry, R. F., and Dash, S. (2003) Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins, Virology 307, 255-265.
14. Epand, R. M. (2003) Fusion peptides and the mechanism of viral fusion, Biochim. Biophys. Acta 1614, 116-121.
15. Peisajovich, S. G., and Shai, Y. (2003) Viral fusion proteins: multiple regions contribute to membrane fusion, Biochim. Biophys. Acta 1614, 122-129.
16. Hahn, Y. S. (2003) Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion?, Curr. Opin. Immunol. 15, 443-449.
17. Alter, H. (1995) To C or not to C: these are the questions, Blood 85, 1681-1695.
18. Grakoui, A., Shoukry, N. H., Woollard, D. J., Han, J. H., Hanson, H. L., Ghrayeb, J., Murthy, K. K., Rice, C. M., and Walker, C. M. (2003) HCV persistence and immune evasion in the absence of T cell help, Science 302, 659-662.
19. Racanelli, V., and Rehermann, B. (2003) Hepatitis C virus infection: when silence is deception, Trends Immunol. 24, 456-464.
20. Guillén, J., Pérez-Berná, A. J., Moreno, M. R., and Villalaín, J. (2005) Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/18-mer peptide scan: implications for the viral fusion mechanism, J. Virol. 79, 1743-1752.
21. Moreno, M. R., Pascual, R., and Villalaín, J. (2004) Identification of membrane-active regions of the HIV-1 envelope glycoprotein gp41 using a 15-mer gp41-peptide scan, Biochim. Biophys. Acta 1661, 97-105.
22. Shin, J., Shum, P., and Thompson, D. H. (2003) Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids, J. Control Release 91, 187-200.
23. Meers, P., Ali, S., Erukulla, R., and Janoff, A. S. (2000) Novel inner monolayer fusion assays reveal differential monolayer mixing associated with cation-dependent membrane fusion, Biochim. Biophys. Acta 1467, 227-243.
24. Böttcher, C. S. F., Van Gent, C. M., and Fries, C. (1961) A rapid and sensitive submicro phosphorous determination, Anal. Chim. Acta 24, 203-204.
25. Struck, D. K., Hoekstra, D., and Pagano, R. E. (1981) Use of resonance energy transfer to monitor membrane fusion, Biochemistry 20, 4093-4099.
26. Engelman, D. M., Steitz, T. A., and Goldman, A. (1986) Identifying nonpolar transbilayer helices in amino acid sequences of membrane proteins, Annu. Rev. Biophys. Biophys. Chem. 15, 321-353.
27. White S. H., and Wimley, W. C. (1999) Membrane protein folding and stability: physical principles, Annu. Rev. Biophys. Biomol. Struct. 28, 319-365.
28. Wimley, W. C., and White, S. H. (1996) Experimentally determined hydrophobicity scale for proteins at membrane interfaces, Nat. Struct. Biol. 3, 842-848.
29. Drummer, H. E., and Poumbourios, P. (2004) Hepatitis C virus glycoprotein E2 contains a membrane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization and viral entry, J. Biol. Chem. 279, 30066-30072.
30. Patel, A. H., Wood, J., Penin, F., Dubuisson, J., and McKeating, J. A. (2000) Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding, J. Gen. Virol. 81, 2873-2883.
31. Brazzoli, M., Helenius, A., Foung, S. K., Houghton, M., Abrignani, S., and Merola, M. (2005) Folding and dimerization of hepatitis C virus E1 and E2 glycoproteins in stably transfected CHO cells, Virology 332, 438-453.
32. Yagnik, A. T., Lahm, A., Meola, A., Roccasecca, R. M., Ercole, B. B., Nicosia, A., and Tramontane, A. (2000) A model for the hepatitis C virus envelope glycoprotein E2, Proteins 40, 355-366.
33. Bretscher, M. S. (1985) The molecules of the cell membrane, Sci. Am. 253, 100-109.
34. Jahn, R., and Grubmüller, H. (2002) Membrane fusion, Curr. Opin. Cell Biol. 14, 488-495.
35. Nieva, J. L., Gofti, F. M., and Alonso, A. (1989) Liposome fusion catalytically induced by phospholipase C, Biochemistry 28, 7364-7367.
36. Blümenthal, R., Clague, M. J., Durell, S. R., and Epand, R. M. (2003) Membrane fusion, Chem. Rev. 103, 53-69.
37. Chernomordik, L. V., and Kozlov, M. M. (2005) Membrane hemifusion: Crossing a chasm in two leaps, Cell 123, 375-382.
38. Schibli, D. J., and Weissenhorn, W. (2004) Class I and class II viral fusion protein structures reveal similar principles in membrane fusion, Mol. Membr. Biol. 21, 361-371.
39. Gallo, S. A., Finnegan, C. M., Viard, M., Raviv, Y., Dimitrov, A. S., Rawat, S. S., Puri, A., Durell, S., and Blumenthal, R. (2003) The HIV Env-mediated fusion reaction, Biochim. Biophys. Acta 1614, 36-50.
40. Op De Beeck, A., Voisset, C., Bartosch, B., Ciczora, Y., Cocquerel, L., Keck, Z., Foung, S., Cosset, F. L., and Dubuisson, J. (2004) Characterization of functional hepatitis C virus envelope glycoproteins, J. Virol. 78, 2994-3002.
41. Flint, M., Thomas, J. M., Maidens, C. M., Shotton, C., Levy, S., Barclay, W. S., and McKeating, J. A. (1999) Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein, J. Virol. 73, 6782-6790.
42. Ciccaglione, A. R., Costantino, A., Marcantonio, C., Equestre, M., Geraci, A., and Rapicetta, M. (2001) Mutagenesis of hepatitis C virus E1 protein affects its membrane-permeabilizing activity, J. Gen. Virol. 82, 2243-2250.
43. Migliaccio, C. T., Follis, K. E., Matsuura, Y., and Nunberg, J. H. (2004) Evidence for a polytopic form of the E1 envelope glycoprotein of hepatitis C virus, Virus Res. 105, 47-57.
44. Kurihara, C., Tsuzuki, Y., Hokari, R., Nakashima, H., Mataki, N., Kuroki, M., Kawaguchi, A., Nagao, S., Kondo, T., and Miura, S. (2004) A highly hydrophobic domain within hypervariable region 1 may be related to the entry of hepatitis C virus into cultured human hepatoma cells, J. Med. Virol. 74, 546-555.
45. Ahn, A., Gibbons, D. L., and Kielian, M. (2002) The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domain, J. Virol. 76, 3267-3275.
46. Nguyen, D. H., and Hildreth, J. E. K. (2000) Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts, J. Virol. 74, 3264-3272.
47. Lavillette, D., Bartosch, B., Nourrisson, D., Verney, G., Cosset, F. L., Penin, F., and Pécheur, E. I. (2005) Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes, J. Biol. Chem. (in press).
48. Contreras, L. M., Aranda, F. J., Gavilanes, F., González-Ros, J. M., and Villalaín, J. (2001) Structure and interaction with membrane model systems of a peptide derived from the major epitope region of HIV protein gp41: implications on viral fusion mechanism, Biochemistry 40, 3196-3207.
49. Pascual, R., Moreno, M. R., and Villalaín, J. (2005) A peptide pertaining to the loop segment of human immunodeficiency virus gp41 binds and interacts with model biomembranes: implications for the fusion mechanism, J. Virol. 79, 5142-5152.
50. Pascual, R., Contreras, M., Fedorov, A., Prieto, M. J. E., and Villalaín, J. (2005) Interaction of a peptide derived from the N-heptad repeat region of gp41 env ectodomain with model membranes. Modulation of phospholipid phase behavior, Biochemistry 44, 14275-14288.
51. Sáez-Cirión, A., Arrondo, J. L., Gomara, M. J., Lorizate, M., Iloro, I., Melikyan, G., and Nieva, J. L. (2003) Structural and functional roles of HIV-1 gp41 pretransmembrane sequence segmentation, Biophys. J. 85, 3769-3780.
52. Earp, L. J., Delos, S. E., Park, H. E., and White, J. M. (2004) The many mechanisms of viral membrane fusion proteins, Curr. Top. Microbiol. Immunol. 285, 25-66.